SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0000950103-19-004515
Filing Date
2019-04-03
Accepted
2019-04-03 08:04:00
Documents
4
Group Members
022019 MERGER SUBSIDIARY, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-T/A dp104884_sctota3.htm SC TO-T/A 51529
2 EXHIBIT (A)(5)(XIII) dp104884_ex-a5xiii.htm EX-99.(A)(5)(XIII) 79910
3 EXHIBIT (A)(5)(XIV) dp104884_ex-a5xiv.htm EX-99.(A)(5)(XIV) 21008
4 GRAPHIC image_002.gif GRAPHIC 1286
  Complete submission text file 0000950103-19-004515.txt   155890
Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080
Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893
ROCHE HOLDINGS INC (Filed by) CIK: 0000904566 (see all company filings)

IRS No.: 510304944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 0000

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-88577 | Film No.: 19727506
SIC: 2836 Biological Products, (No Diagnostic Substances)